Psoriasis: Pathogenesis, Clinical Manifestations, and Nail Findings
Underlying Cause of Psoriasis
Psoriasis is a genetic, systemic, inflammatory, chronic disorder driven by inappropriate activation of cutaneous T cells and dendritic cells, leading to excessive cytokine release (particularly IL-23 and IL-17) that causes keratinocyte hyperproliferation and chronic inflammation. 1, 2 The disease can be modified by environmental factors and has strong genetic susceptibility, as evidenced by your patient's family history of psoriasis 1.
The pathogenesis involves:
- Immune dysregulation: Overactivation of T cells and dendritic cells in the skin
- Cytokine cascade: Release of inflammatory mediators (IL-23, IL-17, TNF-alpha) that perpetuate inflammation
- Keratinocyte hyperproliferation: Rapid skin cell turnover manifesting as characteristic plaques
- Genetic predisposition: Multiple susceptibility loci identified, including chromosome 16 regions 1
This is fundamentally a multisystem inflammatory disease, not just a skin condition—it affects approximately 2% of the population and is associated with significant systemic comorbidities 1, 2.
Common Signs and Symptoms
The hallmark presentation is well-demarcated, erythematous (red) plaques with silvery scale, accompanied by pruritus (itching) and often pain. 1, 2
Primary Cutaneous Features:
- Plaque-type psoriasis (most common): Thick, raised, red plaques with silvery-white scale
- Distribution: Scalp, elbows, knees, presacral region most commonly affected, though any skin area can be involved including palms, soles, and genitalia 2
- Pruritus: Often severe and significantly impacts quality of life 1
- Scaling: Characteristic silvery scale that distinguishes psoriasis from other inflammatory conditions
Clinical Variants Your Patient May Exhibit:
- Guttate: Small (1-10mm) salmon-pink papules with fine scale, more common in younger patients (<30 years) 1
- Inverse: Erythematous plaques with minimal scale in skin folds (axillary, genital, inframammary areas) 1
- Pustular: Visible pustules on erythematous background (less common but severe) 1
- Erythrodermic: Generalized erythema with systemic symptoms like fever and malaise (rare but serious) 1
Important Quality of Life Impact:
The disease causes disfiguring, scaling, and erythematous plaques that may be painful or severely pruritic and cause significant quality of life issues 1. It is a chronic disease that waxes and wanes throughout a patient's lifetime with few spontaneous remissions 1.
Characteristic Nail Findings on Inspection and Palpation
The four cardinal nail findings in psoriasis are: (1) pitting, (2) onycholysis, (3) subungual hyperkeratosis, and (4) oil-drop sign (salmon patches). 1
Prevalence and Clinical Significance:
- Fingernails affected in approximately 50% of all psoriasis patients
- Toenails affected in 35% of patients 1
- Up to 90% of patients with psoriatic arthritis have nail changes, making nail examination critical for identifying joint disease risk 1
Specific Nail Findings by Anatomical Location:
Nail Matrix Involvement:
- Pitting: Small depressions in the nail plate (most common finding, seen in 62.2% of nail psoriasis cases) 3
- Leukonychia: White discoloration of the nail
- Red spots in the lunula: Visible in the half-moon area
- Crumbling: Severe nail dystrophy with matrix destruction 4
Nail Bed Involvement:
- Onycholysis: Separation of the nail plate from the nail bed (most common overall finding, present in 80-93.3% of cases) 5, 3
- Subungual hyperkeratosis: Thickening under the nail plate (75.5-80% of cases) 5, 3
- Oil-drop sign (salmon patches): Yellow-brown discoloration resembling an oil drop under the nail 1
- Splinter hemorrhages: Linear red-brown streaks under the nail 6
On Palpation:
- Nails may feel thickened and rough
- Subungual hyperkeratosis creates palpable elevation
- In trachyonychia variant, nail surface feels characteristically rough 7
Clinical Pearls and Pitfalls:
Critical Association: Nail psoriasis severity correlates strongly with:
- Duration of disease (P < 0.001) 3
- Skin disease severity (PASI scores, P < 0.001) 3
- Risk of psoriatic arthritis development (P < 0.05) 3
Common Pitfall: Always consider onychomycosis as a differential diagnosis or coexisting condition—fungal elements were found in 26% of nail psoriasis cases in one study 5. When in doubt, perform PAS staining or fungal culture.
Therapeutic Challenge: Nail psoriasis is recognized as a significant therapeutic challenge and often requires more aggressive systemic therapy rather than topical treatments alone 1.
Examination Approach:
Systematically examine all 20 nails (fingernails and toenails) for:
- Surface changes: Pitting, roughness, crumbling
- Color changes: Oil-drop sign, leukonychia, splinter hemorrhages
- Structural changes: Onycholysis, subungual hyperkeratosis
- Nail fold: Look for psoriatic paronychia 6
Given your patient's 2-year history and worsening symptoms, thorough nail examination is essential as nail involvement may indicate need for systemic therapy and increased vigilance for psoriatic arthritis development.